XTRA:AFX
XTRA:AFXMedical Equipment

Assessing Carl Zeiss Meditec (XTRA:AFX) Valuation Ahead Of German Corporate Conference Presentation

Carl Zeiss Meditec (XTRA:AFX) is set to engage investors at the 25th German Corporate Conference in Frankfurt, where its CFO and Investor Relations head plan to discuss the business and address market questions. See our latest analysis for Carl Zeiss Meditec. At a share price of €39.44, Carl Zeiss Meditec has seen pressure on momentum, with a 90 day share price return of a 17.35% decline and a 1 year total shareholder return of a 17.28% loss, so investors will be watching the conference for...
XTRA:DBK
XTRA:DBKCapital Markets

Does Deutsche Bank (XTRA:DBK) Offer Value After 86.2% One‑Year Share Price Surge?

If you are wondering whether Deutsche Bank's current share price gives you good value for your money, you are not alone. This article focuses squarely on what you might be paying for each euro of underlying business. After a 1.5% move over the last week, 1.8% over the past month, flat year to date and an 86.2% return over the past year, Deutsche Bank's share price invites a closer look at what is baked into expectations. Recent coverage has highlighted Deutsche Bank's ongoing efforts to...
XTRA:RDC
XTRA:RDCConsumer Retailing

Assessing Redcare Pharmacy (XTRA:RDC) Valuation After Strong 2025 Sales Update

Sales update puts Redcare Pharmacy in focus Redcare Pharmacy (XTRA:RDC) is back on investors’ radar after reporting fourth quarter 2025 group sales of €794 million, compared with €675 million a year earlier, alongside full year sales of €2.9b versus €2.4b in 2024. See our latest analysis for Redcare Pharmacy. Despite the strong sales update, Redcare Pharmacy’s share price has had a weak run, with a 90 day share price return of 24.46% decline and a 1 year total shareholder return of 45.89%...
XTRA:MBG
XTRA:MBGAuto

Is Mercedes-Benz Group (XTRA:MBG) Attractive After Recent Share Price Weakness?

If you are wondering whether Mercedes-Benz Group is attractively priced right now, this article walks through what the current share price really reflects. The stock closed at €58.82, with returns of a 2.6% decline over 7 days, a 1.7% decline over 30 days, a 5.0% decline year to date, a 16.0% return over 1 year, 13.2% over 3 years and 65.6% over 5 years. This gives you a mix of shorter term weakness and longer term gains to think about. Recent coverage around Mercedes-Benz Group has focused...
XTRA:BAS
XTRA:BASChemicals

How BASF’s Eco-Friendly Haircare Launch Could Shape Its Beauty Strategy for Investors (XTRA:BAS)

At Cosmet’Agora 2026 in Paris, BASF’s Personal Care business showcased its Beyond Beauty vision by launching new hybrid formulation concepts and unveiling two ingredients, Aloversil™ for men’s hair density support and Dehyquart® S18, a biodegradable conditioning agent for haircare. An interesting angle is how BASF is pairing performance claims with sustainability credentials, using upcycled sea buckthorn byproducts and readily biodegradable chemistry to align cosmetics innovation with...
XTRA:BC8
XTRA:BC8IT

Will AI-Driven Managed Services Shift Bechtle's (XTRA:BC8) Revenue Mix Toward More Resilient Contracts?

Recent coverage indicates that Bechtle AG’s AI-related services are helping drive higher-margin projects and growing recurring managed-service bookings across its European customer base. This shift toward AI-enabled, service-based work highlights how Bechtle may be reshaping its revenue mix toward more resilient, contract-driven income streams. Next, we’ll examine how rising AI-driven, higher-margin managed-service demand could influence Bechtle’s existing investment narrative and risk...